You
are here: Home: CCU 2 | 2003: Howard
S Hochster, MD: Select publications
Select publications
Publications discussed by Dr Hochster
Gamelin E et al. Clinical aspects and molecular basis of oxaliplatin
neurotoxicity: Current
management and development of preventive measures. Semin Oncol 2002;29
(5 Suppl 15):21-33. Abstract
Gamelin E et al. Prevention of oxaliplatin peripheral sensory neuropathy
by Ca+ gluconate/Mg+
chloride infusions: A retrospective study. Proc ASCO 2002;Abstract
624.
Goldberg RM et al. N9741: Oxaliplatin (oxal) or CPT-11 + 5-fluorouracil
(5FU)/leucovorin (LV) or oxal
+ CPT-11 in advanced colorectal cancer (CRC). Initial toxicity and response
data from a GI
Intergroup study. Proc ASCO 2002;Abstract
511.
Goldberg RM et al. N9741: Oxaliplatin (Oxal) or CPT-11 + 5-fluorouracil
(5FU)/leucovorin (LV) or
oxal + CPT-11 in advanced colorectal cancer (CRC). Updated efficacy and quality
of life (QOL) data
from an Intergroup study. Proc ASCO 2003:Abstract
1009.
Grolleau F et al. A possible explanation for a neurotoxic effect of
the anticancer agent oxaliplatin on
neuronal voltage-gated sodium channels. J Neurophysiol 2001;85:2293-97. Abstract
Adjuvant chemotherapy after hepatic resection for colorectal metastases
Ambiru S et al. Adjuvant regional chemotherapy after hepatic resection
for colorectal metastases. Br J Surg 1999;86(8):1025-31. Abstract
Belli G et al. Liver resection for hepatic metastases: 15 years of
experience. J Hepatobiliary Pancreat
Surg 2002;9(5):607-13. Abstract
Berlin J et al. Phase II evaluation of treatment of complete resection
of hepatic metastases from
colorectal cancer and adjuvant hepatic arterial infusion of floxuridine: An
Eastern Cooperative
Oncology Group Study (PB083). Am J Clin Oncol 1999;22(3):291-3. Abstract
Curley SA et al. Adjuvant hepatic arterial infusion chemotherapy after
curative resection of
colorectal liver metastases. Am J Surg 1993;166(6):743-6; discussion 746-8.
Abstract
Figueras J et al. Resection rate and effect of postoperative chemotherapy
on survival after surgery for
colorectal liver metastases. Br J Surg 2001;88(7):980-5. Abstract
Hodgson WJ et al. Treatment of colorectal hepatic metastases by intrahepatic
chemotherapy alone or
as an adjuvant to complete or partial removal of metastatic disease. Ann Surg
1986;203(4):420-5.
Abstract
Kemeny MM et al. Combined-modality treatment for resectable metastatic
colorectal carcinoma to
the liver: Surgical resection of hepatic metastases in combination with continuous
infusion of
chemotherapy — an intergroup study. J Clin Oncol 2002;20(6):1499-505.
Abstract
Kemeny N et al. Hepatic arterial infusion of chemotherapy after resection
of hepatic metastases from
colorectal cancer. N Engl J Med 1999;341(27):2039-48. Abstract
Khushalani NI et al. Regional chemotherapy is indicated after surgical
resection of colorectal
metastases to the liver: A debate. J Surg Oncol 2003;82(1):65-72. Abstract
Liu LX et al. Current treatment for liver metastases from colorectal
cancer. World J Gastroenterol
2003;9(2):193-200. Abstract
Lorenz M et al. Randomized trial of surgery versus surgery followed
by adjuvant hepatic arterial
infusion with 5-fluorouracil and folinic acid for liver metastases
of colorectal cancer. German
Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) Ann
Surg 1998;228(6):756-62. Abstract
Nonami T et al. Regional adjuvant chemotherapy after partial hepatectomy
for metastatic colorectal
carcinoma. Semin Oncol 1997;24(2 Suppl 6):S6-130-S6-134. Abstract
O'Connell MJ et al. Clinical trial of adjuvant chemotherapy after
surgical resection of colorectal
cancer metastatic to the liver. Mayo Clin Proc 1985;60(8):517-20.
Abstract
Tono T et al. Limited but definite efficacy of prophylactic hepatic
arterial infusion chemotherapy
after curative resection of colorectal liver metastases: A randomized
study. Cancer 2000;88(7):1549-56.
Abstract
Wagman LD et al. A prospective, randomized evaluation of the
treatment of colorectal cancer
metastatic to the liver. J Clin Oncol 1990;8(11):1885-93. Abstract
|
